Genscript Biotech Corporation GNNSF
4.28 USD 0.00 (+0.00%)
Regular-session close
4.50 Day range 4.50
1.30 52-week range 6.35
- YTD
- +157.83%
- 1 year
- +103.81%
News
seekingalpha.com Genscript Biotech Corporation (GNNSF) Q2 2026 Earnings Call Transcript Genscript Biotech Corporation (GNNSF) Q2 2026 Earnings Call Transcript
seekingalpha.com Genscript Biotech Corporation (GNNSF) Q4 2025 Earnings Call Transcript Genscript Biotech Corporation (GNNSF) Q4 2025 Earnings Call Transcript
prnewswire.com GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth Group Performance Revenue: US$959.5 million, +61.4% year-on-year Gross profit: US$553.2 million, +103.3% year-on-year Adjusted net profit: US$230.3 million, +285.0% year-on-year Business Units'…
seekingalpha.com Genscript Biotech Corporation (GNNSF) Q2 2025 Earnings Call Transcript Genscript Biotech Corporation (OTCPK:GNNSF) Q2 2025 Earnings Conference Call August 17, 2025 7:00 PM ET Company Participants Aixi Bai - General Manager of Bestzyme Allen Guo - CEO of ProBio Josie…
prnewswire.com GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation PISCATAWAY, N.J. , Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548),…
prnewswire.com GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader PISCATAWAY, N.J. , July 31, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG…
prnewswire.com GenScript Biotech Corporation Reports FY 2024 Results Strategic deconsolidation of Legend Biotech unlocked significant value, while core businesses experienced rapid growth. PISCATAWAY, N.J.
prnewswire.com The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development LONDON , Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech…
prnewswire.com GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia PISCATAWAY, N.J. , Nov. 10, 2024 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations…
seekingalpha.com GenScript Biotech Corporation (GNNSF) Q2 2024 Earnings Call Transcript GenScript Biotech Corporation (OTCPK:GNNSF) Q2 2024 Results Conference Call August 11, 2024 7:15 PM ET Company Participants Shiniu Wei - Chief Financial Officer Robin Meng - Chairman of the Board…
prnewswire.com GenScript Biotech Reports First Half 2024 Results Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development Impressive Financial Growth: The group reported a 43.5% increase in revenue,…
prnewswire.com GenScript Biotech Corporation Launches FLASH Gene Service: The Fastest and Most Affordable Gene Synthesis Solution on the Market PISCATAWAY, N.J. , June 18, 2024 /PRNewswire/ -- GenScript Biotech Corporation, renowned for its relentless innovation in synthetic biology and industry-leading gene synthesis services, is excited to…
wsj.com GenScript Biotech Shares Drop After U.S. Lawmakers Scrutinize Chinese Ties Shares of GenScript Biotech plunged in Hong Kong amid concerns that the company could face U.S. scrutiny due to alleged ties with the Chinese government.
reuters.com US lawmakers ask FBI for briefing on GenScript Biotech's links to China The U.S. House of Representatives committee on China has asked the FBI and the intelligence community for a briefing on GenScript Biotechnology Co and three subsidiaries to determine if the Chinese…
prnewswire.com GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications GenScript continues to build on its fast and dependable in vitro transcription RNA synthesis service, offering a new self-amplifying RNA format that enhances the potency and efficacy of vaccines,…
businesswire.com Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing SAN FRANCISCO--(BUSINESS WIRE)-- #manufacturing--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech…
prnewswire.com GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint PISCATAWAY, N.J., April 24, 2024 /PRNewswire/ -- Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023…
prnewswire.com Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing Robotic automation of GenScript's market-leading cell isolation solution provides an enhanced approach for a time-consuming phase of cell therapy, improving output and reducing human error…
prnewswire.com GenScript Biotech officially joins SBTi to fulfill its sustainability commitment PISCATAWAY, N.J. , April 15, 2024 /PRNewswire/ -- On April 15, GenScript Biotech Corporation ("GenScript"), a world's leading technology and service provider of life science R&D and manufacture,…
prnewswire.com GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance PISCATAWAY, N.J. , March 26, 2024 /PRNewswire/ -- GenScript, a global leader in life science research and application services, is excited to announce that it has been awarded the Bronze Medal by the…